Clinical Trial Update: I PREVENT - Irbesartan In Hypertensive Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for irbesartan in hypertensive patients with diabetes; the study (NCT00362258) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED